Currently, several strategies based on mechanotransduction are being studied, such as blocking tumor cell interaction through the glycoprotein vitronectin, which reduces the tumor’s invasive capacity [101], or the use of metformin in cancer, which acts on stromal cells by decreasing ECM rigidity and reprogramming tumor cell metabolism towards less aggressive phenotypes [136]. This evidence concerns the gene VTN and neoplasm.